Raptakos Brett

What Raptakos Brett does

Raptakos, Brett & Company Limited is a privately-held Indian pharmaceutical and nutraceutical manufacturer founded in 1930 and headquartered in Mumbai. The company operates across three principal product verticals — pharmaceuticals (controlled-release formulations, haematinics, respiratory, GI, pain management, vitamins and minerals), nutraceuticals (infant milk substitutes and complementary foods under the Lactodex and Threptin brands, plus maternal and geriatric supplements), and active pharmaceutical ingredients — and also runs two services businesses: Raptakos, Brett Test Laboratories Ltd. (RBTL), a NABL- and FDA-accredited analytical testing lab, and a contract research services division offering formulation development and stability studies. Its proprietary DRCM (Diffusion Rate Controlling Membrane) drug delivery technology underpins multiple controlled-release products including Duralyn CR, Fericap CR, Subsyde CR, Durasal CR, and Takol CR, enabling 24-hour therapeutic release from a single dose.

The company manufactures at six WHO-GMP certified facilities located in Thane, Dahej, Roha, Karad, Chennai, and Alwar, and sells through a hybrid go-to-market model: a domestic field force of over 1,000 medical representatives operating across 14 branches to engage prescribing clinicians, supplemented by direct-to-consumer listings on five major Indian online pharmacy platforms (1mg, Netmeds, PharmEasy, Apollo Pharmacy, MedPlusMart). International revenues are generated through wholly-owned sales offices in the UK, Indonesia, and distribution arrangements in Ivory Coast, Kenya, and 10+ additional emerging markets across Africa, Southeast Asia, and the Middle East. Quality credentials include WHO GMP, ISO 9001:2015, NABL (ISO 17025-2017), FDA accreditation, and Government of India recognized Export House status.

Revenue mechanics are predominantly B2B/B2B2C one-time product sales through pharmacy distribution and medical representative prescription pull, with a smaller professional services revenue stream from RBTL testing and contract research. Sub-brands include Lactodex (infant nutrition franchise), Threptin (protein supplements), Hepatoglobine (iron supplements), Calcinol (calcium), and Montage's Products (acquired analgesics brand). The customer base is healthcare professionals (prescribers) and end consumers across India and 15+ export markets. Ownership is private with no disclosed institutional investors, and a Notice of Amalgamation and Arrangement indicates ongoing corporate restructuring.

Name

Raptakos Brett

Legal name

Raptakos, Brett & Company Limited

Website

https://raptakos.com

Company type

Private

Founded year

1930

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Raptakos, Brett & Company Limited is a 1930-founded Indian pharmaceutical and nutraceutical manufacturer that develops, produces, and markets prescription drugs, infant nutrition, controlled-release formulations via proprietary DRCM technology, APIs, and analytical testing services across India and 15+ export markets.

Ownership category

akta.pro rank

Product category

Pharmaceuticals and Nutraceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Food Manufacturing (311)

SIC

Pharmaceutical Preparations (2834), Food And Kindred Products (2000), Services-Testing Laboratories (8734), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Multivitamins & Daily Packs (CRADAGAC)

akta.pro secondary industries

Vitamins & Minerals (Single Nutrients) (CRADAGAB), Probiotics & Digestive Health Supplements (CRADAGAF), Food, Feed & Nutraceutical Analytical Testing (HLAGADAN)

Keywords

• Pharmaceutical manufacturing
• Nutraceutical supplements
• Infant nutrition formulas
• Active pharmaceutical ingredients
• Contract research services

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices13 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products: Revenue from pharmaceutical formulations covering therapeutic groups such as Vitamin and Mineral Supplements, Haematinics, Gastrointestinals, Digestive Enzymes, NSAIDs, respiratory products, and pain management products. Distributed through medical representatives and pharmacies.
2. Nutraceutical Products: Revenue from specialized infant foods for low birth weight and term infants, lactose intolerant infants, supplements for pregnant women and lactating mothers, growing children, geriatrics, and critically ill patients.
3. API (Active Pharmaceutical Ingredients): Revenue from manufacturing and selling Active Pharmaceutical Ingredients including Calcium Glubionate, Calcium Lactobionate, Chlorpheniramine Maleate Controlled Released Pellets, Colloidal Bismuth Subcitrate, Ferric Ammonium Citrate, and others.
4. Testing and Analytical Services: Revenue from Raptakos, Brett Test Laboratories Ltd. providing analytical testing services to pharmaceuticals, nutraceuticals, cosmetics, agro, water, chemical and microbiological industries.
5. Contract Research Services: Revenue from contract research including formulation development from laboratory to commercial scale, stability studies, and analytical method development for pharmaceuticals, nutraceuticals, herbal formulations and APIs.
6. International Exports: Revenue from international business involving export of nutraceuticals, formulations, and APIs to more than 15 countries.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Raptakos Brett manufactures and markets a broad portfolio of pharmaceutical formulations, nutraceutical supplements (including infant nutrition, maternal nutrition, and adult health products), and active pharmaceutical ingredients (APIs). The company also operates Raptakos Brett Test Laboratories Ltd (RBTL), providing pharmaceutical testing, analytical, and contract research services. Its products are sold across India through a field force serving medical professionals and through online pharmacy partners, with exports to more than 15 countries.

Product overview

Raptakos, Brett & Company Limited is an ISO 9001:2015 certified pharmaceutical and nutraceutical company established in 1930. The company operates a diversified portfolio across three main segments: Pharmaceuticals (covering respiratory, pain management, GI, digestive enzymes, vitamin and mineral supplements, and haematinics), Nutraceuticals (including infant formulas, complementary foods, and nutritional supplements), and Active Pharmaceutical Ingredients (APIs). The pharmaceutical portfolio includes products under brands like Duralyn CR, Fericap CR, IsoFlav, Hepatoglobine, Calcinol, and Subsyde. The nutraceutical range includes Lactodex infant formulas (Lactodex 1, 2, 3, 4, GOLD, Premium, LBW variants), Threptin protein supplements, Easifud complementary foods, and various vitamin/mineral formulations. The company also offers testing services through Raptakos, Brett Test Laboratories Ltd. (RBTL) and contract research services. The company has developed proprietary DRCM (Diffusion Rate Controlling Membrane) technology for controlled-release drug delivery. Manufacturing facilities are WHO-GMP certified and located at Thane, Dahej, Roha, Karad, Chennai, and Alwar, serving over 15 countries globally through an extensive distribution network of 14 branches and 1000+ field personnel.

Differentiator

Problem solved

Functional benefit

Brands

• Lactodex: Infant milk substitutes and follow-up formulas including Lactodex 1, 2, 3, 4, GOLD 1, GOLD 2, Premium 1, Premium 2, HMF, LBW, LBW Plus, and NMW 1
• Threptin
• Easifud
• Hovite
• Neopeptine
• Hepatoglobine
• Nutrimom
• Trophox
• Zerolac
• Veelac
• Arbivit 3
• Duralyn CR
• Durasal CR
• Fericap CR
• Subsyde CR
• Takol CR
• IsoFlav
• AmloKOS
• Brettkits
• Taxkos
• Neogadine
• Eidikos

Products and services

• Lactodex (Infant Formula Range) Infant milk substitutes and follow-up formula range for newborns, infants, and young children, including starter formulas, follow-up formulas, and maternal nutrition. Sold through pediatricians and pharmacies.
• Threptin Protein supplement brand offering biscuits, protein powder, and micronized protein products for children and adults. Sold through medical professionals and pharmacies.
• Easifud / Veelac Complementary baby foods and infant cereals including Easifud and Veelac ranges for infants and young children.
• Zerolac Lactose-free milk substitute formulated for infants and children with lactose intolerance.
• Nutrimom Nutritional supplement designed for pregnant and lactating women to support maternal and fetal health.
• Hovite Multivitamin and mineral health tonic used for general nutritional supplementation and deficiency prevention.
• Neopeptine Digestive enzyme preparation in drops and liquid forms for relief of digestive discomfort and indigestion in infants and adults.
• Hepatoglobine Iron supplement formulated for treatment and prevention of iron-deficiency anemia across age groups.
• Trophox Specialized protein supplement formulated for the dietary management of diabetic patients.
• Arbivit 3 Cholecalciferol (Vitamin D3) supplement indicated for prevention and treatment of vitamin D deficiency.
• Controlled-Release (CR) Pharmaceutical Range Controlled-release prescription formulations covering therapeutic areas such as respiratory (asthma), hematinics (iron deficiency), and analgesics (pain management), sold through physicians and pharmacies.
• IsoFlav and AmloKOS IsoFlav isoflavone supplement for post-menopausal women, and AmloKOS (amlodipine besylate) tablets for the treatment of hypertension.
• Brettkits Infant teething biscuits and complementary snack products for young children.
• Active Pharmaceutical Ingredients (APIs) Manufactured active pharmaceutical ingredients (APIs) such as Neogadine API and other drug substances produced at WHO-GMP certified facilities, supplied to other pharmaceutical companies.
• DRCM Technology Platform Proprietary Dual Release Control Mechanism (DRCM) technology platform used in the development of controlled-release pharmaceutical formulations.
• Raptakos Brett Test Laboratories (RBTL) - Testing and Contract Research Services Through its subsidiary Raptakos Brett Test Laboratories Ltd (RBTL), the company provides pharmaceutical testing, analytical, pharmacopeial, and contract research services to external clients.

Quantifiable outcome

• 24-hour therapeutic drug concentration achievable with single dose through DRCM technology

Named customers1 record

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Nestlé India: Sells infant nutrition (Cerelac, Lactogen, NAN) and health supplements in India. Directly competes with Raptakos' Lactodex and Threptin ranges and shares the same pharma-style distribution to pediatricians and mothers.
• Abbott India: Indian subsidiary of Abbott with a comparable mix of pharmaceutical formulations, nutrition (including infant formula), and consumer health products. Competes directly with Raptakos' Lactodex in infant nutrition and with multiple pharma SKUs in the Indian market.
• Mead Johnson Nutrition (Reckitt): Global infant formula leader (Enfamil) and a direct competitor to Raptakos' Lactodex brand in India and export markets. Comparable in serving low-birth-weight and term infant segments with premium formulations.
• Cipla: Indian pharma manufacturer with overlapping therapeutic categories (respiratory, GI, vitamins) and strong API/formulations integration similar to Raptakos' API-plus-formulation model.
• Zydus Lifesciences: Indian pharma company with a comparable API + formulations + nutrition portfolio and significant international presence. Overlaps on vitamins, haematinics, GI, and contract research.
• GlaxoSmithKline Consumer Healthcare (HUL): Direct competitor in vitamins, mineral supplements, and nutrition (e.g., Horlicks). Competes with Raptakos' Threptin protein supplements and Hovite multivitamins in the Indian consumer health market.

Others

• SRL Diagnostics: India's largest diagnostic and analytical testing network. Comparable to Raptakos' RBTL business in providing accredited laboratory testing services to pharma, food, and clinical clients.
• Syngene International: Indian CRO offering formulation development, stability studies, and analytical method development services. Directly comparable to Raptakos' Contract Research Services (RBCRS) business in scope and customer base.

Broad incumbents

• Dabur: Large Indian FMCG/health company with ayurvedic supplements, nutrition (Dabur Honey, Real) and OTC health products. Competes with Raptakos' Threptin and OTC nutrition in the Indian consumer channel.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company with a broad formulations portfolio overlapping Raptakos' therapeutic categories (vitamins, haematinics, GI, pain, respiratory). Significantly larger scale and field force.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/raptakosl

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Raptakos Brett